Section VI：Probiotics,Prebiotics and Postbiotics - Session 8：Next-Generation Probiotics:Akkermansia muciniphila (AKK) |
2027-02-25 13:30-15:50 |
| |
| 2027-02-25 13:30-13:50 Domestic and International Research Progress and Industrialization Status of Akkermansia muciniphila (AKK)Lu Wenwei,Vice Dean,School of Food Science and Technology,Jiangnan University |
| 2027-02-25 13:50-14:10 Research Progress on AKK Safety:A Systematic Review Based on Preclinical and Clinical EvidenceChina National Center for Food Safety Risk Assessment |
| 2027-02-25 14:10-14:30 Next-Generation Probiotic:Development and Application of Akkermansia muciniphila Akk11 in Metabolic Health RegulationLiu Litai,R&D Manager,Weikan Probiotics (Suzhou) Co.,Ltd. |
| 2027-02-25 14:30-14:50 Akkermansia muciniphila MucT®:How a scientific discovery becomes a leading innovation?Dr Anneleen Segers,Senior Scientist,The Akkermansia Company (part of Danone Group) |
| 2027-02-25 14:50-15:10 Mechanistic Study of AKK ONE Strain in Improving Enteritis and Cognitive FunctionLi Nan,R&D Director,Sirio Pharma (China) Co.,Ltd. |
| 2027-02-25 15:10-15:30 Clinical Study of AKK Intervention in Obese,Overweight,and PCOS PopulationsProf. Chen Tingtao,Nanchang University |
| 2027-02-25 15:30-15:50 Mechanistic Exploration of AKK in Alzheimer's Disease ModelsProf. Ren Dayong,Jilin Agricultural University |
